Q.1
Do you think 2012 will be a better year for the pharma industry than 2011?
Yes
No
Q.2
What is the chance of getting the product through clinical trials?
3%
9%
19%
32%
Q.3
How much money/investment does the Ddn life sciences industry need each year?
$100 million
$250 million
$500 million
$1.0 billion
Q.4
What is the #1 action Big Pharma needs to get back to solid growth?
Refocus R&D on breakthrough innovation
Better communicate the value of innovative medicine to payers
Allocate promotional spend differently
Diversify into OTC, generics, biosimilars
Change its public image
Q.5
In the genomic arena, do you think Big Pharma has already fallen too far behind other commercial interests to ever catch up?
Yes
No
There's a genomic arena?
Q.6
The pharmaceutical industry works for:
Governments
Patients
Investors
A broad range of stakeholders
The weekend
Q.7
How often was an appeal launched to Health Canada to review a suspension of NOC?
Once a year
Happened five times in the last 10 years
Was never used in 30 years, AXR was the first case
Q.8
Once the appeal was launched, who was reviewing the dossier?
A Senate Committee
A New Drug Committee formed of 3 independent experts
Health Canada
Create your own free
online surveys
now!
Powered by
Surveydaddy